ClinicalTrials.Veeva

Menu

Identifying Optimal PEEP After Lung Transplantation (PEEP-LuTX)

P

Policlinico Hospital

Status

Completed

Conditions

Primary Graft Dysfunction
Lung Transplant; Complications

Treatments

Other: PEEP

Study type

Interventional

Funder types

Other

Identifiers

NCT05691205
0058711-U

Details and patient eligibility

About

Lung Transplantation (LuTX) is the curative treatment for selected patients with end-stage lung disease. Primary Graft Dysfunction (PGD), a specific form of respiratory failure occurring within the first 72 hours after graft reperfusion, represents the most common complication after LuTX.

Actual recommendation regarding management of mechanical ventilation of the lung graft immediately after LuTX are based only on opinion experts and not on clinical trials. Optimization of Positive End-Expiratory Pressure might contribute to both prevention and treatment of PGD.

In this interventional single-center non-pharmacological study (with medical device), in the immediate postoperative period of patients who are undergone LuTX, we will evaluate the effects of varying levels of PEEP upon: - lung and chest wall mechanics, - intrapulmonary shunt fraction; - distribution of ventilation and perfusion; - gas exchange.

The final aim is to find the optimal level of PEEP in this patient's cohort

Enrollment

47 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Recipient of LUTX
  • Age > 18 years
  • Signed informed consent

Exclusion criteria

  • Age < 18 years
  • Already undergone LUTX
  • Major hemodynamic instability along the 24 hours following LUTX: systolic arterial pressure < 90 mmHg and/or heart rate > 120 beat/min and/or high dose vasopressor requirement (norepinephrine > 0.3 mcg/kg/min and/or epinephrine > 0.2 mcg/kg/min and/or dobutamine > 8mcg/kg/min)
  • Documented post-LUTX endobronchial plasma leak requiring high levels of PEEP > 15 cmH2O

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

47 participants in 1 patient group

PEEP-LuTX
Experimental group
Description:
Within 48h after LuTX we will evaluate the effects of three levels of PEEP (14\>10\>6 cmH2O) upon: - lung and chest wall mechanics, - intrapulmonary shunt fraction; - distribution of ventilation and perfusion; - gas exchange.
Treatment:
Other: PEEP

Trial contacts and locations

1

Loading...

Central trial contact

Vittorio Scaravilli

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems